BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 261664)

  • 1. The effect of kallikrein on central effects of acetylcholine in rats receiving indomethacin and prostaglandin E1.
    Bodzenta A; Moniuszko-Jakoniuk J; Wiśniewski K
    Pol J Pharmacol Pharm; 1979; 31(6):595-603. PubMed ID: 261664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinins and central effects of the acetylcholine.
    Wiśniewski K; Bodzenta A
    Acta Neurobiol Exp (Wars); 1975; 35(1):85-92. PubMed ID: 1136870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of prostaglandin E1 on central cholinergic mechanisms.
    Bodzenta A; Wisniewski K
    Pharmacology; 1977; 15(2):143-51. PubMed ID: 847011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The participation of prostaglandins in the action of kinins on the central dopaminergic system in the rat. III. Participation of PGE1 in the action of kinins on the central dopaminergic system.
    Kościelak M; Moniuszko-Jakoniuk J; Wiśniewski K
    Pol J Pharmacol Pharm; 1980; 32(3):371-94. PubMed ID: 6912580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Participation of prostaglandins in the action of kinins on the central dopaminergic system in the rat. I. The action of kinins on the central dopaminergic system after pretreatment with indomethacin.
    Kościelak M; Moniuszko-Jakoniuk J; Wiśniewski K
    Pol J Pharmacol Pharm; 1980; 32(3):343-56. PubMed ID: 6912578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of kinins on the psychomotor activity of rats as evaluated by Lát's test.
    Moniuszko-Jakoniuk J; Wiśniewski K
    Acta Neurobiol Exp (Wars); 1974; 34(5):621-8. PubMed ID: 4447059
    [No Abstract]   [Full Text] [Related]  

  • 7. Further studies on the effect of fibrinopeptides A and B on the central nervous system.
    Bernacka I; Buczko W; Wiśniewski K
    Pol J Pharmacol Pharm; 1981 Nov; 33(4):407-14. PubMed ID: 7329866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central effects of prostaglandins F2alpha and E1.
    Herman ZS; Kmieciak-Kolada K; Wolny HL; Slomińska-Zurek J; Bonczek A
    Pol J Pharmacol Pharm; 1976; 28(5):411-21. PubMed ID: 1012972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation by prostaglandins of the release of acetylcholine and noradrenaline in guinea-pig isolated ileum.
    Kadlec O; Masek K; Seferna I
    J Pharmacol Exp Ther; 1978 Jun; 205(3):635-45. PubMed ID: 660534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the effects of diazepam, hyoscine and oxotremorine on acetylcholine release from the cerebral cortex.
    Petkov V; Georgiev V; Getova D; Petkov VV
    Acta Physiol Pharmacol Bulg; 1983; 9(2):3-13. PubMed ID: 6659979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandins E1 and E2 antagonize indomethacin-induced decrease in survival rate of haemorrhagically shocked rats.
    Perbeck L; Hedqvist P
    Acta Chir Scand Suppl; 1980; 500():91-4. PubMed ID: 6939202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of prostaglandin E1 on acetylcholine release from the cat brain.
    Hársing LG; Illés P; Fürst S; Vizi ES; Knoll J
    Acta Physiol Acad Sci Hung; 1979; 54(2):177-85. PubMed ID: 543406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indomethacin potentiates acetylcholine-induced vasodilation by increasing free radical production.
    De Angelis A; Rinaldi B; Capuano A; Rossi F; Filippelli A
    Br J Pharmacol; 2004 Aug; 142(8):1233-40. PubMed ID: 15265802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proceedings: Influence of prostaglandin E1, indomethacin, calcium and potassium on the action of nociceptive substances.
    Juan H; Lembeck F
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R42. PubMed ID: 4276577
    [No Abstract]   [Full Text] [Related]  

  • 15. Prostaglandin F2alpha reduces the algesic effect of bradykinin by antagonizing the pain enhancing action of endogenously released prostaglandin E.
    Juan H; Lembeck F
    Br J Pharmacol; 1977 Mar; 59(3):385-91. PubMed ID: 843680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central effect of the potent long-acting H1-antihistamine levocabastine.
    Tasaka K; Kamei C; Tsujimoto S; Yoshida T; Aoki I
    Arzneimittelforschung; 1990 Dec; 40(12):1295-9. PubMed ID: 1982750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the mechanism of the sedational state; "tranquilization" evoked by bradykinin or kallikrein in rats.
    Yazaki K
    Adv Exp Med Biol; 1989; 247B():595-600. PubMed ID: 2610096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation and mediation of the action of the renal kallikrein-kinin system by prostaglandins.
    McGiff JC; Itskovitz HD; Terragno A; Wong PY
    Fed Proc; 1976 Feb; 35(2):175-80. PubMed ID: 765161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological modification of the edema produced by combined infusions of prostaglandin E1 and bradykinin in canine forelimbs.
    Prasad CM; Adamski SW; Svensjö E; Grega GJ
    J Pharmacol Exp Ther; 1982 Feb; 220(2):293-8. PubMed ID: 6173476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of nitric oxide and prostaglandin systems in lithium modulation of acetylcholine vasodilation.
    Rahimzadeh-Rofouyi B; Afsharimani B; Moezi L; Ebrahimi F; Mehr SE; Mombeini T; Ghahremani MH; Dehpour AR
    J Cardiovasc Pharmacol; 2007 Dec; 50(6):641-6. PubMed ID: 18091580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.